AEZS - エテルナ・ゼンタリス （AEterna Zentaris Inc.）

Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Rating) (TSE:AEZ) – HC Wainwright reduced their Q1 2023 earnings estimates for shares of Aeterna Zentaris in a research report issued to clients and investors on Tuesday, March 28th. HC Wainwright analyst B. Pachaiyappan now forecasts that the biopharmaceutical company will post earnings per share of ($1.07) for the […]

Aeterna Zentaris press release (AEZS): Q4 GAAP EPS of -$2.56.Revenue of $2.5M (+150.0% Y/Y).The Company had $50.6 million in cash and cash equivalents at December 31, 2022.

TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Thursday reported a loss of $12.5 million in its…

– Company ended the year with $50.6 million in cash, expected to fund operations through 2024 and into 2025 – Executing strategy to streamline advancement of development programs, build upon growing body of data across pipeline, and progress towards go/no-go decision milestones – Ongoing efforts to accelerate recruitment for our DETECT trial and establish partnering rights to Macrilen ™ in the U.S. and Canada

Aeterna Zentaris (AEZS) said Pharmanovia acquired a license to growth hormone therapy Ghryvelin from Aeterna''s existing licensee Consilient Health.Pharmanovia acquired exclusive rights…

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Shocking stocks: Atossa Therapeutics, Inc. (NASDAQ:ATOS 2.38%), Aeterna Zentaris Inc. (NASDAQ:AEZS -0.21%) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Deliciously stocks You Should follow: Verona Pharma plc (NASDAQ:VRNA 3.56%), Aeterna Zentaris Inc. (NASDAQ:AEZS -1.04%) appeared first on Stocks Equity .

Aeterna Zentaris (AEZS) on Monday said it would regain the U.S. and Canadian rights for oral test Macrilen from Danish pharmaceutical company Novo Nordisk (NVO)

Aeterna Zentaris Inc. (NASDAQ:AEZS) shares, rose in value on Friday, 08/05/22, with the stock price up by 3.11% to the previous day’s close as strong demand from buyers drove the stock to $4.97. Actively observing the price movement in the last trading, the stock closed the session at $4.82, falling within a range of $4.6801 … Aeterna Zentaris Inc. (NASDAQ: AEZS) Is A Blank Check For Growth Read More »

Aeterna Zentaris press release (AEZS): Q2 GAAP EPS of -$0.87.Revenue of -$0.2M (vs

Gainers Embark Technology, Inc. (NASDAQ: EMBK ) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share. Exicure, Inc. (NASDAQ: XCUR ) rose 36.4% to $0.1450 in pre-market trading after the company reported a $5 million raise in private placement transaction priced at market premium. Electra Battery Materials Corporation (NASDAQ: ELBM ) shares rose 34.5% to $4.99 in pre-market trading after the company issued an an Update on its Cobalt-Copper Mineral Project in Idaho. Desktop Metal, Inc. (NYSE: DM ) rose 23.3% to $1.64 in pre-market trading. Desktop Metal priced its $100 million convertible senior notes offering. New Concept Energy, Inc. (NYSE: GBR ) rose 19.7% to $2.25 in pre-market trading after declining 5% on Tuesday. Zai Lab Limited (NASDAQ: ZLAB ) rose 17.6% to $30.87 in pre-market trading following better-than-expected quarterly results. Evolve Transition Infrastructure LP (NYSE: SNMP ) shares rose 16.3% to $0.4650 in pre-market trading. Veru Inc. (NASDAQ: VERU ) rose 14.1% to $8.89 in pre-market trading.

Aeterna Zentaris Inc. (NASDAQ:AEZS) with the stream of -1.07% also noticed, India NuCana plc (NASDAQ:NCNA) encountered a rapid change of -2.97% in the last hour of Wednesday’s trading session. Aeterna … The post Investors Focused Stock: Aeterna Zentaris Inc. (NASDAQ:AEZS), NuCana plc (NASDAQ:NCNA) appeared first on Stocks Equity .

Aeterna Zentaris Inc (NASDAQ: AEZS ) provided an update for its ongoing pivotal Phase 3 study AEZS-130-P02 (the DETECT-trial) of macimorelin to diagnose childhood-onset growth hormone deficiency (CGHD). The DETECT trial investigates the efficacy and safety of a single oral dose of 1.0 mg/kg macimorelin acetate as a growth hormone stimulation test … Full story available on Benzinga.com

Aeterna Zentaris (AEZS) said that enrollment of a phase 3 trial of macimorelin in childhood-onset growth hormone deficiency is delayed due to ongoing impacts from COVID-19 and Ukraine.

Cinedigm Corp. (NASDAQ:CIDM) with the stream of -1.11% also noticed, India Aeterna Zentaris Inc. (NASDAQ:AEZS) encountered a rapid change of -0.97% in the last hour of Thursday’s trading session. Cinedigm … The post Beholding Stock: Cinedigm Corp. (NASDAQ:CIDM), Aeterna Zentaris Inc. (NASDAQ:AEZS) appeared first on Stocks Equity .